The Management of Severe Hypertension

Seminars in Perinatology

Volumn 33, Issue 3, 2009, Pages 138-142

  Magee, Laura A ^a,b   von Dadelszen, Peter ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

pre eclampsia; pregnancy; severe hypertension; systolic blood pressure

Indexed keywords

DIAZOXIDE; ERGOMETRINE; GLUCONATE CALCIUM; GLYCERYL TRINITRATE; HYDRALAZINE; LABETALOL; MAGNESIUM SULFATE; METHYLDOPA; NICARDIPINE; NIFEDIPINE;

ANAMNESIS; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DIASTOLIC HYPERTENSION; DRUG DOSAGE FORM COMPARISON; ENDOTRACHEAL INTUBATION; FETUS ELECTROCARDIOGRAPHY; FLUID RESUSCITATION; GENERAL ANESTHESIA; HUMAN; LABORATORY TEST; LUNG EDEMA; MATERNAL HYPERTENSION; NONHUMAN; OBSTETRIC ANESTHESIA; PHYSICAL EXAMINATION; PLASMA VOLUME; PREECLAMPSIA; PRIORITY JOURNAL; PULSE PRESSURE; REPEATED DRUG DOSE; REVIEW; SEIZURE; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION;

ANTIHYPERTENSIVE AGENTS; FEMALE; HEART RATE, FETAL; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR;

EID: 65649137381     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semperi.2009.02.001     Document Type: Review

References (39)

1. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 183 (2000) S1-S22
2. Brown M.A., Hague W.M., Higgins J., et al. The detection, investigation and management of hypertension in pregnancy: Executive summary. Aust N Z J Obstet Gynaecol 40 (2000) 133-138
3. Rey E., Le Lorier J., Burgess E., et al. Report of the Canadian Hypertension Society Consensus Conference. 3. Pharmacologic treatment of hypertensive disorders in pregnancy. CMAJ 157 (1997) 1245-1254
4. Lower S.A., Brown M.A., Dekker G., et al. Guidelines for the management of hypertensive disorders of pregnancy 2008. www.somanz.org
5. Magee L.A., Helewa M., Rey E., et al. SOGC clinical practice guideline: Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can 30 (2008) S1-S48
6. Golara M., Jones C., Randhawa M., et al. Inflationary oscillometric blood pressure monitoring: Validation of the Omron-MIT. Blood Press Monit 7 (2002) 325-328
7. Reinders A., Cuckson A.C., Lee J.T., et al. An accurate automated blood pressure device for use in pregnancy and pre-eclampsia: The Microlife 3BTO-A. Br J Obstet Gynaecol 112 (2005) 915-920
8. O'Brien E., Petrie J., Littler W., et al. An outline of the revised British Hypertension Society protocol for the evaluation of blood pressure measuring devices. J Hypertens 11 (1993) 677-679
9. Villar J., Say L., Shennan A., et al. Methodological and technical issues related to the diagnosis, screening, prevention, and treatment of pre-eclampsia and eclampsia. Int J Gynecol Obstet 85 Suppl 1 (2004) S28-S41
10. Martin Jr. J.N., Thigpen B.D., Moore R.C., et al. Stroke and severe preeclampsia and eclampsia: A paradigm shift focusing on systolic blood pressure. Obstet Gynecol 105 (2005) 246-254
11. Why Mothers Die 1997-1999: The Confidential Enquiries into Maternal Deaths in the UK (2001), RCOG, London
12. Lindenstrom E., Boysen G., and Nyboe J. Influence of systolic and diastolic blood pressure on stroke risk: A prospective observational study. Am J Epidemiol 142 (1995) 1279-1290
13. Euser A.G., and Cipolla M.J. Cerebral blood flow autoregulation and edema formation during pregnancy in anesthetized rats. Hypertension 49 (2007) 334-340
14. August P. Management of hypertension in pregnancy. UpToDate online version 16.3 (October 2008)
15. Lyons G. Saving mothers' lives: Confidential enquiry into maternal and child health 2003-05. Int J Obstet Anesth 17 (2008) 103-105
16. Magee L.A., Cham C., Waterman E.J., et al. Hydralazine for treatment of severe hypertension in pregnancy: Meta-analysis. Br Med J 327 (2003) 955-960
17. Duley L., and Henderson-Smart D.J. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev 4 (2002) CD001449
18. Caetano M., Ornstein M., von Dadelszen P., et al. A survey of Canadian practitioners regarding the management of the hypertensive disorders of pregnancy. Hypertens Pregnancy 23 (2003) 61-74
19. Tuffnell D.J., Jankowicz D., Lindow S.W., et al. Outcomes of severe pre-eclampsia/eclampsia in Yorkshire 1999/2003. Br J Obstet Gynaecol 112 (2005) 875-880
20. Brown M.A., Buddle M.L., Farrell T., et al. Efficacy and safety of nifedipine tablets for the acute treatment of severe hypertension in pregnancy. Am J Obstet Gynecol 187 (2002) 1046-1050
21. Magee L.A., Cote A.M., and von Dadelszen P. Nifedipine for severe hypertension in pregnancy: Emotion or evidence?. J Obstet Gynaecol Can 27 (2005) 260-262
22. Magee L.A., Miremadi S., Li J., et al. Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia. Am J Obstet Gynecol 193 (2005) 153-163
23. Duley L., Farrell B., Spark P., et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate?. The magpie trial: A randomised placebo-controlled trial. Lancet 359 (2002) 1877-1890
24. Scardo J.A., Hogg B.B., and Newman R.B. Favorable hemodynamic effects of magnesium sulfate in preeclampsia. Am J Obstet Gynecol 173 (1995) 1249-1253
25. Cotton D.B., Gonik B., and Dorman K.F. Cardiovascular alterations in severe pregnancy-induced hypertension: Acute effects of intravenous magnesium sulfate. Am J Obstet Gynecol 148 (1984) 162-165
26. Mroczek W.J., Lee W.R., and Davidov M.E. Effect of magnesium sulfate on cardiovascular hemodynamics. Angiology 28 (1977) 720-724
27. Pritchard J.A. The use of the magnesium ion in the management of eclamptogenic toxemias. Surg Gynecol Obstet 100 (1955) 131-140
28. Young B.K., and Weinstein H.M. Effects of magnesium sulfate on toxemic patients in labor. Obstet Gynecol 49 (1977) 681-685
29. Cetin A., Yurtcu N., Guvenal T., et al. The effect of Glyceryl trinitrate on hypertension in women with severe preeclampsia, HELLP syndrome, and eclampsia. Hypertens Pregnancy 23 (2004) 37-46
30. Neri I., Valensise H., Facchinetti F., et al. 24-hour ambulatory blood pressure monitoring: A comparison between transdermal glyceryl-trinitrate and oral nifedipine. Hypertens Pregnancy 18 (1999) 107-113
31. Michael C.A. Intravenous labetalol and intravenous diazoxide in severe hypertension complicating pregnancy. Aust N Z J Obstet Gynaecol 26 (1986) 26-29
32. Hennessy A., Thornton C.E., Makris A., et al. A randomised comparison of hydralazine and mini-bolus diazoxide for hypertensive emergencies in pregnancy: The PIVOT trial. Aust N Z J Obstet Gynaecol 47 (2007) 279-285
33. Sass N., Itamoto C.H., Silva M.P., et al. Does sodium nitroprusside kill babies?. A systematic review. Sao Paulo Med J 125 (2007) 108-111
34. Magee L., and Sadeghi S. Prevention and treatment of postpartum hypertension. Cochrane Database Syst Rev 1 (2005) CD004351
35. Gallery E.D., Hunyor S.N., and Gyory A.Z. Plasma volume contraction: A significant factor in both pregnancy-associated hypertension (pre-eclampsia) and chronic hypertension in pregnancy. Q J Med 48 (1979) 593-602
36. Waterman E.J., Magee L.A., Lim K.I., et al. Do commonly used oral antihypertensives alter fetal or neonatal heart rate characteristics?. A systematic review. Hypertens Pregnancy 23 (2004) 155-169
37. Ganzevoort W., Rep A., Bonsel G.J., et al. A randomised controlled trial comparing two temporising management strategies, one with and one without plasma volume expansion, for severe and early onset pre-eclampsia. Br J Obstet Gynaecol 112 (2005) 1358-1368
38. Magee L.A., Ornstein M.P., and von Dadelszen P. Fortnightly review: Management of hypertension in pregnancy. Br Med J 318 (1999) 1332-1336
39. Confidential Enquiry into Maternal and Child Health: Why Mothers Die 2000-2002 (2004), RCOG, London